Fundraising Fox
Mel-Mont Medical
Doral, US · Founded 2020 · Delaware corporation
Find your way into Mel-Mont Medical
Sign up to see every warm intro you have to Mel-Mont Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mel-Mont Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Mél Mont Medical develops a self-collection vaginal sampling device called Mía for cervical cancer screening that detects high-risk HPV DNA and active oncogenic E6/E7 mRNA overexpression without a speculum. The test is designed for women over 25 and provides actionable results to guide follow-up treatment decisions and prevent unnecessary procedures.
Founders & leadership
OG
Octavio Gonzalez ParedoExecutive
MT
Michael TorresExecutive
FM
Frank MelendezNamed on SEC filing
LM
Liliana MontesNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$10.2M disclosed across 3 rounds · 2020–2025
▶$250KraisedDec 2025 · 3 investors · BiotechnologyRule 506(b)
▶$250KraisedDec 2025 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael TorresExecutive Officer
- Octavio Gonzalez ParedoExecutive Officer, Director
- Liliana MontesExecutive Officer, Director
- Frank MelendezExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $250K
- Minimum investment
- $25K
- Proceeds to insiders
- $450K
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.9MraisedDec 2025 · 69 investors · BiotechnologyRule 506(b)
▶$6.9MraisedDec 2025 · 69 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Octavio Gonzalez ParedoExecutive Officer, Director
- Frank MelendezExecutive Officer, Director
- Michael TorresExecutive Officer
- Liliana MontesExecutive Officer, Director
- Offering amount
- $7.5M
- Amount sold
- $6.9M
- Minimum investment
- $25K
- Finders' fees
- $50K
- Proceeds to insiders
- $950K
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedNov 2020 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedNov 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Liliana MontesExecutive Officer, Director
- Frank MelendezExecutive Officer, Director
- Octavio Gonzalez ParedoExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Mel-Mont Medical.
Frequently asked questions
- What does Mel-Mont Medical do?
- Mél Mont Medical develops a self-collection vaginal sampling device called Mía for cervical cancer screening that detects high-risk HPV DNA and active oncogenic E6/E7 mRNA overexpression without a speculum. The test is designed for women over 25 and provides actionable results to guide follow-up treatment decisions and prevent unnecessary procedures.
- How much funding has Mel-Mont Medical raised?
- Mel-Mont Medical has disclosed $10.2M raised across 3 rounds.
- Where is Mel-Mont Medical headquartered?
- Mel-Mont Medical is headquartered in Doral, US.